Ali Mohamed
Vice President - Chemistry, Manufacturing & Control Immatics
Senior operations and manufacturing development leader with an extensive background and experience managing successful cGMP operations, facilities, and supply chain materials management for the cell & gene therapy industry.
Plays an integral leadership role by fostering cross-functional collaboration, and building strong and diverse teams in dynamic environment. Over 15 years of experience managing the various facets of the cell & gene therapy industry with all the necessary regulatory compliance.
Seminars
Thursday 26th February 2026
Panel Discussion: Manufacturing Leaner & More Affordably to Accelerate Cell Therapy Development in Europe
1:30 pm
- Identify key cost drivers in cell therapy manufacturing and discuss practical strategies to reduce them without compromising quality
- Debate approaches to efficient scale-out and scale-up that enable broader patient access while meeting regulatory and quality standards
Thursday 26th February 2026
Driving Efficiency & Unlocking Scalability for PRAME Cell Therapy Manufacturing
2:00 pm
- Anzu-cel is TCR T-cell therapy directed against PRAME, a target expressed in more than 50 cancers
- Scaling out efficiently: horizontal expansion to increase speed and throughput
- Preparing for commercial manufacturing through operational excellence
